[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.176.107. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Citations 0
Correction
June 15, 2005

Efficacy and Tolerability of Long-Acting Injectable Naltrexone for Alcohol Dependence: A Randomized Controlled Trial—Correction

JAMA. 2005;293(23):2864. doi:10.1001/jama.293.23.2864

Additional Financial Disclosure: Stephanie O'Malley, PhD, a coauthor of the Original Communication entitled “Efficacy and Tolerability of Long-Acting Injectable Naltrexone for Alcohol Dependence: A Randomized Controlled Trial” published in the April 6, 2005, issue of JAMA (2005;293:1617-1625) has reported an additional financial disclosure. Dr O'Malley is an inventor on a patent held by Yale University entitled “Smoking Cessation Treatments Using Naltrexone and Related Compounds.”

×